Market Highlights for today reflect significant developments in the healthcare sector. One of the standout announcements came from Biohaven Pharmaceuticals (BHVN), which showcased its innovative neuroscience portfolio with an impressive 20 presentations at the 2024 American Academy of Neurology (AAN) Annual Meeting. This strong presence underscores Biohaven's commitment to advancing neurological research and development.
For more details on Biohaven's latest updates, you can Read More.